Read More Healthcare Industry News MiraDx’s ASTRO 2025 breakthrough: Can PROSTOX ultra finally make radiation therapy safer for prostate cancer patients? MiraDx’s PROSTOX ultra test at ASTRO 2025 shows high-risk prostate cancer patients can avoid SBRT toxicity with safer regimens. Read the full story. byPallavi MadhirajuSeptember 28, 2025